Please enable JavaScript to continue using this application.

Compare $GANX vs $MNOV | Chartloom

Compare

$GANX vs $MNOV

Gain Therapeutics Inc · MediciNova Inc

GANX

Gain Therapeutics Inc

MNOV

MediciNova Inc

Compare $GANX vs $MNOV

Comparing Gain Therapeutics Inc and MediciNova Inc

GANXGain Therapeutics Inc

MNOVMediciNova Inc

GANXGain Therapeutics Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.4%

52W performance

-20.8%

FCF yield

-27.1%

MNOVMediciNova Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

583.8%

YTD performance

14.3%

52W performance

24.6%

FCF yield

-12.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GANX

MNOV

Detailed metrics comparison

GANX

Gain Therapeutics Inc

MNOV

MediciNova Inc

Market Cap

GANX$70M

MNOV$75M

Enterprise Value

GANX$57M

MNOV$49M

Price

GANX$1.64

MNOV$1.52

P/E Ratio

GANXN/A

MNOVN/A

P/S Ratio

GANX466.44x

MNOV81.28x

EV/Sales

GANX386.81x

MNOV53.67x

EV/EBITDA

GANX0.00x

MNOV0.00x

P/B Ratio

GANX6.61x

MNOV2.35x

P/FCF Ratio

GANXN/A

MNOVN/A

EV/FCF

GANX-3.02x

MNOV-5.41x

PEG Ratio

GANXN/A

MNOVN/A

Forward P/E (NTM)

GANXN/A

MNOVN/A

Forward P/S (NTM)

GANXN/A

MNOVN/A

Revenue (TTM)

GANX$0

MNOV$920K

Revenue Growth (YoY)

GANXN/A

MNOV583.8%

Forward Rev Growth

GANX180.0%

MNOV-2.9%

Gross Margin (TTM)

GANX0.0%

MNOV37.8%

Operating Margin (TTM)

GANX0.0%

MNOV0.0%

EBITDA Margin (TTM)

GANX0.0%

MNOV-1285.4%

Net Margin (TTM)

GANX0.0%

MNOV-1168.3%

FCF Margin (TTM)

GANXN/A

MNOV-991.3%

Net Income (TTM)

GANX$-20M

MNOV$-11M

FCF (TTM)

GANX$-19M

MNOV$-9M

EPS (TTM)

GANX-$0.47

MNOV-$0.22

ROE (TTM)

GANX-16158.0%

MNOV-2651.0%

ROA (TTM)

GANX-11836.0%

MNOV-2439.0%

ROIC (TTM)

GANX-15673.0%

MNOV-2651.0%

Cash

GANX$13M

MNOV$25M

Debt

GANX$344K

MNOV$0

Net Cash/Debt

GANX$13M

MNOV$25M

Current Ratio (TTM)

GANX4.36x

MNOV8.75x

Quick Ratio (TTM)

GANX4.11x

MNOV8.58x

Debt/Equity (TTM)

GANX0.03x

MNOV0.00x

Debt/Assets (TTM)

GANX0.0%

MNOV0.0%

Interest Coverage (TTM)

GANXN/A

MNOVN/A

Net Debt/EBITDA (TTM)

GANX0.00x

MNOV0.00x

Beta

GANX0.21

MNOV0.69

52W Performance

GANX-20.8%

MNOV24.6%

YTD Performance

GANX-48.4%

MNOV14.3%

% from 52W High

GANX-62.2%

MNOV-61.0%

% from 52W Low

GANX7.2%

MNOV30.1%

Asset Turnover (TTM)

GANX0.01x

MNOV0.02x

FCF Yield (TTM)

GANX-27.1%

MNOV-12.2%

Earnings Yield (TTM)

GANX-28.7%

MNOV-14.4%

Dividend Yield (TTM)

GANXN/A

MNOVN/A

Rule of 40

GANX0.0

MNOV-407.5

EV/GP/RG

GANXN/A

MNOVN/A

Ticker research

View GANX research View MNOV research

Metric	GANX Gain Therapeutics Inc	MNOV MediciNova Inc
Market & Valuation
Market Cap	$70M	$75M
Enterprise Value	$57M	$49M
Price	$1.64	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	466.44x	81.28x
EV/Sales	386.81x	53.67x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.61x	2.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-5.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$920K
Revenue Growth (YoY)	N/A	583.8%
Forward Rev Growth	180.0%	-2.9%
Profitability
Gross Margin (TTM)	0.0%	37.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1285.4%
Net Margin (TTM)	0.0%	-1168.3%
FCF Margin (TTM)	N/A	-991.3%
Net Income (TTM)	$-20M	$-11M
FCF (TTM)	$-19M	$-9M
EPS (TTM)	-$0.47	-$0.22
ROE (TTM)	-16158.0%	-2651.0%
ROA (TTM)	-11836.0%	-2439.0%
ROIC (TTM)	-15673.0%	-2651.0%
Financial Health
Cash	$13M	$25M
Debt	$344K	$0
Net Cash/Debt	$13M	$25M
Current Ratio (TTM)	4.36x	8.75x
Quick Ratio (TTM)	4.11x	8.58x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.21	0.69
52W Performance	-20.8%	24.6%
YTD Performance	-48.4%	14.3%
% from 52W High	-62.2%	-61.0%
% from 52W Low	7.2%	30.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-27.1%	-12.2%
Earnings Yield (TTM)	-28.7%	-14.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-407.5
EV/GP/RG	N/A	N/A
Ticker research	View GANX research	View MNOV research

Valuation

P/S Ratio

MNOV

81.28x

GANX

466.44x

EV/FCF

MNOV

-5.41x

GANX

-3.02x

Growth & revenue

Revenue Growth TTM

MNOV

583.8%

Forward Revenue Growth

GANX

180.0%

MNOV

-2.9%

Profitability & performance

Gross Margin

MNOV

37.8%

GANX

0.0%

ROE

MNOV

-2651.0%

GANX

-16158.0%

FCF Yield %

MNOV

-12.2%

GANX

-27.1%

52-Week Performance

MNOV

24.6%

GANX

-20.8%

Detailed metrics comparison

GANX

Gain Therapeutics Inc

MNOV

MediciNova Inc

Market Cap

GANX$70M

MNOV$75M

Enterprise Value

GANX$57M

MNOV$49M

Price

GANX$1.64

MNOV$1.52

P/E Ratio

GANXN/A

MNOVN/A

P/S Ratio

GANX466.44x

MNOV81.28x

EV/Sales

GANX386.81x

MNOV53.67x

EV/EBITDA

GANX0.00x

MNOV0.00x

P/B Ratio

GANX6.61x

MNOV2.35x

P/FCF Ratio

GANXN/A

MNOVN/A

EV/FCF

GANX-3.02x

MNOV-5.41x

PEG Ratio

GANXN/A

MNOVN/A

Forward P/E (NTM)

GANXN/A

MNOVN/A

Forward P/S (NTM)

GANXN/A

MNOVN/A

Revenue (TTM)

GANX$0

MNOV$920K

Revenue Growth (YoY)

GANXN/A

MNOV583.8%

Forward Rev Growth

GANX180.0%

MNOV-2.9%

Gross Margin (TTM)

GANX0.0%

MNOV37.8%

Operating Margin (TTM)

GANX0.0%

MNOV0.0%

EBITDA Margin (TTM)

GANX0.0%

MNOV-1285.4%

Net Margin (TTM)

GANX0.0%

MNOV-1168.3%

FCF Margin (TTM)

GANXN/A

MNOV-991.3%

Net Income (TTM)

GANX$-20M

MNOV$-11M

FCF (TTM)

GANX$-19M

MNOV$-9M

EPS (TTM)

GANX-$0.47

MNOV-$0.22

ROE (TTM)

GANX-16158.0%

MNOV-2651.0%

ROA (TTM)

GANX-11836.0%

MNOV-2439.0%

ROIC (TTM)

GANX-15673.0%

MNOV-2651.0%

Cash

GANX$13M

MNOV$25M

Debt

GANX$344K

MNOV$0

Net Cash/Debt

GANX$13M

MNOV$25M

Current Ratio (TTM)

GANX4.36x

MNOV8.75x

Quick Ratio (TTM)

GANX4.11x

MNOV8.58x

Debt/Equity (TTM)

GANX0.03x

MNOV0.00x

Debt/Assets (TTM)

GANX0.0%

MNOV0.0%

Interest Coverage (TTM)

GANXN/A

MNOVN/A

Net Debt/EBITDA (TTM)

GANX0.00x

MNOV0.00x

Beta

GANX0.21

MNOV0.69

52W Performance

GANX-20.8%

MNOV24.6%

YTD Performance

GANX-48.4%

MNOV14.3%

% from 52W High

GANX-62.2%

MNOV-61.0%

% from 52W Low

GANX7.2%

MNOV30.1%

Asset Turnover (TTM)

GANX0.01x

MNOV0.02x

FCF Yield (TTM)

GANX-27.1%

MNOV-12.2%

Earnings Yield (TTM)

GANX-28.7%

MNOV-14.4%

Dividend Yield (TTM)

GANXN/A

MNOVN/A

Rule of 40

GANX0.0

MNOV-407.5

EV/GP/RG

GANXN/A

MNOVN/A

Ticker research

View GANX research View MNOV research

Metric	GANX Gain Therapeutics Inc	MNOV MediciNova Inc
Market & Valuation
Market Cap	$70M	$75M
Enterprise Value	$57M	$49M
Price	$1.64	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	466.44x	81.28x
EV/Sales	386.81x	53.67x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.61x	2.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-5.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$920K
Revenue Growth (YoY)	N/A	583.8%
Forward Rev Growth	180.0%	-2.9%
Profitability
Gross Margin (TTM)	0.0%	37.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1285.4%
Net Margin (TTM)	0.0%	-1168.3%
FCF Margin (TTM)	N/A	-991.3%
Net Income (TTM)	$-20M	$-11M
FCF (TTM)	$-19M	$-9M
EPS (TTM)	-$0.47	-$0.22
ROE (TTM)	-16158.0%	-2651.0%
ROA (TTM)	-11836.0%	-2439.0%
ROIC (TTM)	-15673.0%	-2651.0%
Financial Health
Cash	$13M	$25M
Debt	$344K	$0
Net Cash/Debt	$13M	$25M
Current Ratio (TTM)	4.36x	8.75x
Quick Ratio (TTM)	4.11x	8.58x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.21	0.69
52W Performance	-20.8%	24.6%
YTD Performance	-48.4%	14.3%
% from 52W High	-62.2%	-61.0%
% from 52W Low	7.2%	30.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-27.1%	-12.2%
Earnings Yield (TTM)	-28.7%	-14.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-407.5
EV/GP/RG	N/A	N/A
Ticker research	View GANX research	View MNOV research